,siRNA:

Donya Esmaeilpour1, Ponnurengam Malliappan Sivakumar2,3, Arezoo Khosravi4,5

  • 1Center for Nanotechnology in Drug Delivery, School of Pharmacy, Shiraz University of Medical Science, Shiraz, 71345-1583, Iran.

Materials today. Bio
|March 11, 2026
PubMed
概括

覆盖着多糖的金属纳米粒子在癌症治疗中提供小干扰RNA (siRNA) 的前景有望. 整合人工智能 (AI) 优化这些纳米载体,以提高疗效和个性化治疗策略.